We recognize that it may be difficult to determine whether two or more closely related protocols should be considered a single study. Generally, if you have research activities that use the same human subjects population, follow the same core research … Continue reading
NIH’s resubmission policy has not changed, but the policy notice highlights some important points: only a single resubmission (A1) of an original application (A0) will be accepted, an A0 application may be submitted following an unsuccessful A0 or A1 application (with a few exceptions), what happens when switching FOAs between the A0 and A1 applications, and generally a change of activity code (e.g., R01) between the A0 and A1 is not allowed, with one exception. Continue reading
The Human Subjects and Clinical Trials Information form appears for all recipients with human subjects studies. However, those who submitted competing applications for due dates on or before January 25, 2018 only need to update inclusion data via the Human … Continue reading
At NIH, we maintain a broad and diverse portfolio of biomedical and behavioral research. To turn discovery into health, promising technologies must move from the laboratory into clinical trials, into the marketplace, into the doctor’s office, and into our every-day lives. A key way to transition promising technologies out of the laboratory is through the commercialization process. Continue reading
Did you know that grant funds can expire? A recent interview with NIH experts on the topic of “Expiring Appropriations” addresses how you know if you have expiring funds, what to do if you find yourself in this situation, and whether money can be restored. This 10 minute conversation is available as both a video and a podcast. Continue reading
In just a few months, approximately 65 NIH & HHS grants process and policy experts will be bringing their expertise to the San Francisco Bay area for the NIH Regional Seminar on Program Funding and Grants Administration. Plan to meet, share, and learn with us over the course of 2-3 days, October 17-19, 2018! Continue reading
If you are proposing a study that will include both an existing dataset and recruitment of new participants, you should provide separate inclusion forms for the existing dataset and the participants to be prospectively recruited. The existing dataset sample can … Continue reading
If the study is considered human subjects’ research and meets the NIH definition of clinical research, then it is subject to the NIH inclusion policy.
In the Final RPPR you should report on the individuals that worked on the project during the last budget period minus any approved no-cost extensions. You can find this and more in the RPPR FAQs.
Have you ever wondered why your grant application must undergo a separate round of peer review—even after a panel of experts initially weighed in on its scientific merit and provided a score to consider when making funding decisions? A new … Continue reading